UBS Group
CALC icon

UBS Group’s CalciMedica CALC Stock Holding History

UBS Group’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3 Sell
2
-1
-33% -$3 ﹤0.01% 11107
2026
Q2 		$16 Hold
3
– – ﹤0.01% 10296
2026
Q1 		$9 Sell
3
-217
-99% -$2.2K ﹤0.01% 10341
2025
Q4 		$7.25K Buy
220
+217
+7,233% +$4.23K ﹤0.01% 8462
2025
Q3 		$52 Sell
3
-3,398
-100% -$48.9K ﹤0.01% 10016
2025
Q2 		$27.2K Buy
3,401
+3,357
+7,630% +$28.8K ﹤0.01% 8231
2025
Q1 		$421 Sell
44
-21
-32% -$262 ﹤0.01% 9785
2024
Q4 		$1.15K Buy
65
+62
+2,067% +$1.09K ﹤0.01% 9300
2024
Q3 		$66 Hold
3
– – ﹤0.01% 9207
2024
Q2 		$59 Hold
3
– – ﹤0.01% 9220
2024
Q1 		$66 Hold
3
– – ﹤0.01% 8892
2023
Q4 		$40 Sell
3
-84
-97% -$1.22K ﹤0.01% 9013
2023
Q3 		$1.16K Buy
87
+84
+2,800% +$1.39K ﹤0.01% 8071
2023
Q2 		$56 Buy
+3
New +$66 ﹤0.01% 8589
2023
Q1 		– Sell
-77
Closed -$2.69K – 9643
2022
Q4 		$2.69K Buy
77
+74
+2,467% +$4.15K ﹤0.01% 9637
2022
Q3 		$0 Sell
3
-225
-99% -$15.9K ﹤0.01% 10362
2022
Q2 		$17K Buy
228
+122
+115% +$8.33K ﹤0.01% 7082
2022
Q1 		$9K Buy
106
+63
+147% +$6K ﹤0.01% 8532
2021
Q4 		$5K Buy
43
+40
+1,333% +$7.77K ﹤0.01% 9377
2021
Q3 		$1K Hold
3
– – ﹤0.01% 9150
2021
Q2 		$1K Sell
3
-26
-90% -$8.53K ﹤0.01% 9128
2021
Q1 		$11K Buy
29
+10
+53% +$15K ﹤0.01% 7848
2020
Q4 		$38K Buy
19
+14
+280% +$20.7K ﹤0.01% 6417
2020
Q3 		$4K Buy
+5
New +$5.21K ﹤0.01% 7392

Other funds holding CALC

Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return
Jane Street
Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

UBS Group's CALC Position: Q3 2026 in Review

UBS Group reduced its CalciMedica (CALC) stake by 33% in Q3 2026, selling an estimated $3 and leaving 2 shares worth $3. The position accounts for ﹤0.01% of the portfolio, ranked #11107.

UBS Group first reported a position in CALC in Q3 2020 and has held it in 24 quarters since. The position peaked at $38K in Q4 2020. 8 funds tracked by Wall St. Rank hold CALC as of Q3 2026.

  • UBS Group held 2 shares of CalciMedica worth $3 as of Q3 2026.
  • UBS Group sold 1 CalciMedica share in Q3 2026, an estimated $3.
  • CalciMedica made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #11107 holding.
  • UBS Group first reported a position in CalciMedica in Q3 2020 and has held it in 24 quarters since.
  • UBS Group's CalciMedica position peaked at $38K in Q4 2020.
  • 8 funds tracked by Wall St. Rank held CalciMedica as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.